118. Use of Intranasal Esketamine for Treatment-Resistant Depression in a Patient With Bilateral Lung Transplantation: A Case Report
Journal of the Academy of Consultation-Liaison Psychiatry · 2026-11 · 67 · S130-S131
DOI: 10.1016/j.jaclp.2026.10.217 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the Academy of Consultation-Liaison Psychiatry, 2026-11. Verfasst von Riley Longtain und 5 weiteren Autor:innen.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Longtain, R., Masters, G., Flores, F. B., Beach, S., Dillon, J., & Restrepo, J. (2026). 118. Use of Intranasal Esketamine for Treatment-Resistant Depression in a Patient With Bilateral Lung Transplantation: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry, 67, S130-S131. https://doi.org/10.1016/j.jaclp.2026.10.217
Vancouver
Longtain R, Masters G, Flores FB, Beach S, Dillon J, Restrepo J. 118. Use of Intranasal Esketamine for Treatment-Resistant Depression in a Patient With Bilateral Lung Transplantation: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry. 2026;67:S130-S131. doi:10.1016/j.jaclp.2026.10.217
BibTeX
@article{Longtain2026,
author = {Longtain, Riley and Masters, Grace and Flores, Francisco Barrera and Beach, Scott and Dillon, John and Restrepo, Judith},
title = {118. Use of Intranasal Esketamine for Treatment-Resistant Depression in a Patient With Bilateral Lung Transplantation: A Case Report},
journal = {Journal of the Academy of Consultation-Liaison Psychiatry},
year = {2026},
volume = {67},
pages = {S130--S131},
doi = {10.1016/j.jaclp.2026.10.217}
}
EUVIMED